CDSCO Audit Checklist for Indian Device Manufacturers – csr medical writing CDSCO Audit Checklist for Indian Device Manufacturers under India MDR 2017 The Central Drugs Standard Control Organization (CDSCO) plays a crucial role in regulating medical devices and combination products in India. The India Medical Device Rules (MDR) 2017 establishes a comprehensive regulatory framework intended to ensure the safety and effectiveness of devices intended for human use. This article presents a detailed CDSCO audit checklist tailored for Indian device manufacturers to facilitate compliance with the MDR. This guide is indispensable for stakeholders involved in csr medical writing, regulatory consulting, and…

Indian Requirements for UDI Implementation (Roadmap and Deadlines) – regulatory consulting pharma Indian Requirements for UDI Implementation (Roadmap and Deadlines) The implementation of Unique Device Identification (UDI) in India is evolving under the framework of the Medical Devices Rules, 2017 (MDR 2017). This comprehensive guide outlines the roadmap and deadlines for regulatory consulting pharma professionals who are directly involved in the development, approval, and compliance of medical devices in India. Understanding the Regulatory Landscape for UDI in India To successfully navigate UDI implementation, it is crucial for stakeholders in the medical devices sector to understand the regulations set forth by…

Labeling Requirements for Devices Under MDR 2017 – regulatory consulting pharma Labeling Requirements for Devices Under MDR 2017 The regulation of medical devices is a critical component of public health safety and efficacy. Under the Medical Device Rules of 2017 (MDR 2017) in India, significant emphasis is placed on the labeling requirements for medical devices to ensure compliance for manufacturers, marketing authorization holders, and healthcare professionals. This step-by-step guide is designed for regulatory affairs, quality assurance, and regulatory consulting pharma professionals involved in the medical device industry, offering a comprehensive overview of the relevant regulations, processes, and documentation necessary to…

How to Handle Device Classification Queries with CDSCO – regulatory consulting pharma How to Handle Device Classification Queries with CDSCO under India MDR 2017 The Central Drugs Standard Control Organization (CDSCO) regulates the approval and classification of medical devices in India under the Medical Device Rules (MDR) of 2017. This comprehensive guide aims to offer a detailed step-by-step approach for regulatory consulting pharma stakeholders on how to navigate device classification queries effectively. It will encompass various aspects including the intricacies of device categorization, the requisite technical documentation, post-market surveillance (PMS) obligations, and compliance actions. Understanding the Medical Device Regulations in…

Registration of Notified Bodies and State Licensing Authorities – writing clinical notes Registration of Notified Bodies and State Licensing Authorities – writing clinical notes The registration of Notified Bodies (NBs) and State Licensing Authorities (SLAs) as mandated by the India Medical Device Rules (MDR) 2017 is a critical process for organizations involved in the medical device and combination product sectors. This tutorial guide provides a comprehensive, step-by-step approach to navigating the complexities of writing clinical notes, technical documentation, and compliance actions associated with these registrations. The target audience includes regulatory affairs professionals, quality assurance teams, and MedTech market access teams…

Overview of Indian Standards and BIS Certification for Devices – regulatory consulting pharma Overview of Indian Standards and BIS Certification for Devices under India MDR 2017 The Indian medical device regulatory framework has evolved significantly, particularly with the introduction of the Medical Device Rules (MDR) in 2017. As a regulatory consulting pharma professional, understanding the nuances of Indian standards and the Bureau of Indian Standards (BIS) certification process is crucial for ensuring compliance in the Indian market. This article outlines the essential steps and technicalities involved in aligning with the India MDR 2017, with a specific focus on BIS certification….

Drug-Device Combination Regulation in India (as per CDSCO) – pharmacovigilance consulting Drug-Device Combination Regulation in India (as per CDSCO) With advancements in medical technology, the integration of drugs and devices, commonly known as drug-device combinations, has gained significant prominence. In India, the regulation of these products falls under the purview of the Central Drugs Standard Control Organization (CDSCO) as per the Medical Devices Rules (MDR) of 2017. This step-by-step guide will elucidate the regulatory landscape for drug-device combinations in India, specifically tailored for stakeholders involved in pharmacovigilance consulting, including regulatory affairs, quality assurance, and medical writing agencies. Understanding Drug-Device Combinations…

Fast Track Approval for COVID and Emergency Use Devices – pharmacovigilance consulting services Fast Track Approval for COVID and Emergency Use Devices under India MDR 2017 In response to the global COVID-19 pandemic, regulatory authorities worldwide have implemented expedited pathways for the approval of medical devices and combination products. In India, this is governed under the Medical Device Rules (MDR) 2017. This article serves as a comprehensive guide for regulatory affairs professionals, quality assurance experts, and market access teams involved in managing pharmacovigilance consulting services during this unprecedented time. We will explore the fast track approval process, necessary technical documentation,…

How India MDR Aligns with Global Harmonization (IMDRF, WHO) – medical writing agencies How India MDR Aligns with Global Harmonization (IMDRF, WHO) – medical writing agencies The medical device regulatory landscape within India, particularly the India Medical Devices Regulations (MDR) established in 2017, significantly impacts the pharmaceutical and medical writing agencies operating within this jurisdiction. Understanding how the India MDR aligns with global harmonization efforts, particularly those led by IMDRF and WHO, is crucial for professionals involved in regulatory affairs, quality assurance, and market access in the MedTech industry. Introduction to India MDR 2017 The India MDR 2017 was enacted…

Role of AERB, NABH, and BIS in Medical Device Regulation – pharmacovigilance research Role of AERB, NABH, and BIS in Medical Device Regulation under India MDR 2017 Introduction to the Regulatory Landscape for Medical Devices in India The regulatory framework for medical devices in India has evolved significantly, particularly with the introduction of the Medical Device Rules (MDR) 2017. This article serves as a comprehensive guide for professionals involved in pharmacovigilance research by detailing the roles of key regulatory bodies in India, namely the Atomic Energy Regulatory Board (AERB), the National Accreditation Board for Hospitals and Healthcare Providers (NABH), and…